Jon Resnick
CEO & DirectorMr. Jon Resnick is CEO & Director of Certara, Inc. from January 1, 2026. He had been President of United States & Canada at IQVIA Holdings Inc. (formerly known as Quintiles IMS Holdings, Inc.) since 2019 and also served as its President of Real-World Insights since October 2016 until 2019. Mr. Resnick serves as a Vice President and General Manager of Real-World Evidence Solutions at IMS Health Holdings, Inc. (alternate name IMS Health Incorporated). Mr. Resnick is responsible for global RWE and health economics and outcomes research initiatives. Mr. Resnick served as an Engagement Director of Cambridge Pharma Consultancy Limited. He joined IMS’s management consulting business in 2002, where he advised pharmaceutical and biotechnology clients on corporate, organizational and product strategy. Since 2006, he served several leadership positions within IMS, including regional leader for the IMS Consulting Group in Europe and practice leader for the Pricing and Market Access business in EMEA. He served as Professional Health and Social Security Staff for the U.S. Senate Committee on Finance in Washington D.C. He was responsible for advising committee members and other senators on policy issues, developing legislation and supporting the legislative process on issues, including Medicare, Medicaid and health reform. He has BA in Political Science from Union College and an MBA from the Kellogg School of Management, Northwestern University, where he majored in Management & Strategy, Finance, Health Industry Management and Biotechnology.
公司职务
- 公司名称Certara, Inc.股票代码CERT职务CEO & Director共事同僚
- RPRobert P. AspburyPresident of Model Informed Discovery & Drug Development
- JEJames E. CashmanIndependent Chairman of the Board
- LELeif E. PedersenSenior Advisor
- AKAdrian K. McKemeyPresident of Development Strategy & Evidence
- JPJulien PerrierPresident & Chief Commercial Officer
- MMMatthew M. WalshIndependent Director
- NKNancy KilleferIndependent Director
- EBEran BroshyIndependent Director
